세계의 호흡기 진단 시장 : 제품 및 서비스 유형별, 검사 유형별, 질환별, 최종사용자별, 지역별(2025-2033년)

The global respiratory diagnostics market size reached USD 8.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.43% during 2025-2033. The growing prevalence of respiratory diseases, rising healthcare expenditure, increasing aging population, and heightened demand for early and accurate diagnosis to improve patient outcomes and manage chronic conditions effectively are some of the factors impelling the market growth.

Respiratory diagnostics refer to the clinical assessment of lung functioning and related processes. It includes several mechanical, imaging and molecular diagnostic tests for detecting asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis. It uses procedures, such as spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray and computed tomography (CT) scan. In some instances, sleep studies are also conducted to diagnose and assess the presence of sleep apnea and nocturnal hypoventilation.

The growing prevalence of respiratory diseases is one of the key factors driving the growth of the market. The increasing number of smokers and consumption of alcohol, coupled with sedentary lifestyle habits and stressful routines, have resulted in rising incidences of COPD and other severe respiratory conditions, such as lung cancer. Furthermore, various technological innovations in respiratory diagnostic testing, including the utilization of Internet of Things (IoT) and Artificial Intelligence (AI) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth. Also, an increase in the demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers and efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all are driving the market for respiratory diagnostics. Other factors contributing to the market growth include enhanced research and development (R&D), rising geriatric population, rapid urbanization and increasing industrial establishments, and growing pollution levels across the globe.

Key Market Segmentation:

Breakup by Product and Service Type:

• Instruments and Services
• Assays and Reagents
• Services and Software

Breakup by Test Type:

• Mechanical Tests
• Obstructive Sleep Apnoea (OSA) Diagnostic Tests
• Imaging Tests
• Traditional Diagnostic Tests
• Molecular Diagnostic Tests
• Others

Breakup by Disease:

• Tuberculosis
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Lung Cancer
• Others

Breakup by End-User:

• Hospitals
• Clinics
• Reference and Clinical Laboratories
• Others

Breakup by Region:

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

Competitive Landscape:

The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific Inc., Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics and COSMED.

Key Questions Answered in This Report:

• How has the global market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and respiratory diagnostics market recent opportunities in the global market?
• What is the impact of each driver, restraint, and opportunity on the global market?
• What are the key regional markets?
• Which countries represent the most attractive market?
• What is the breakup of the market based on the product and service type?
• Which is the most attractive product and service type in the market?
• What is the breakup of the market based on the test type?
• Which is the most attractive test type in the market?
• What is the breakup of the market based on the disease?
• Which is the most attractive disease in the market?
• What is the breakup of the market based on the end-user?
• Which is the most attractive end-user in the market?
• What is the competitive structure of the market?
• Who are the key players/companies in the global market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Respiratory Diagnostics Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Product and Service Type
• 5.5 Market Breakup by Test Type
• 5.6 Market Breakup by Disease
• 5.7 Market Breakup by End-User
• 5.8 Market Breakup by Region
• 5.9 Market Forecast

6 Market Breakup by Product and Service Type

• 6.1 Instruments and Services
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Assays and Reagents
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Services and Software
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Test Type

• 7.1 Mechanical Tests
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Obstructive Sleep Apnoea (OSA) Diagnostic Tests
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Imaging Tests
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Traditional Diagnostic Tests
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Molecular Diagnostic Tests
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by Disease

• 8.1 Tuberculosis
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Asthma
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Chronic Obstructive Pulmonary Disease (COPD)
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Lung Cancer
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Clinics
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Reference and Clinical Laboratories
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Europe
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Asia Pacific
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 Middle East and Africa
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast
• 10.5 Latin America
  • 10.5.1 Market Trends
  • 10.5.2 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Philips Healthcare
  • 14.3.2 Abbott Laboratories
  • 14.3.3 Biomerieux
  • 14.3.4 Becton Dickinson
  • 14.3.5 Thermo Fisher Scientific Inc.
  • 14.3.6 Alere Inc.
  • 14.3.7 Seegene Inc.
  • 14.3.8 3M
  • 14.3.9 Bio-Rad Laboratories Inc.
  • 14.3.10 SDI Diagnostics
  • 14.3.11 COSMED